Insulin degludec (IDeg; Tresibaw) is a novel basal insulin with an ultra-long, flat and stable action profile. In adults, it provides a more consistent glucose-lowering effect and lower rates of hypoglycaemia than glargine (IGlar). Data on children and adolescents are scarce.
The Efficacy of Insulin Degludec in Children and Adolescents with Type 1 Diabetes / Bruzzi, Patrizia; Maltoni, Giulio; Predieri, Barbara; Zucchini, Stefano; Iughetti, Lorenzo. - In: HORMONE RESEARCH IN PAEDIATRICS. - ISSN 1663-2818. - STAMPA. - 86:suppl 1(2016), pp. 85-85. (Intervento presentato al convegno 55th Annual Meeting of the European Society for Paediatric Endocrinology tenutosi a Paris).
The Efficacy of Insulin Degludec in Children and Adolescents with Type 1 Diabetes
BRUZZI, Patrizia;PREDIERI, Barbara;IUGHETTI, Lorenzo
2016
Abstract
Insulin degludec (IDeg; Tresibaw) is a novel basal insulin with an ultra-long, flat and stable action profile. In adults, it provides a more consistent glucose-lowering effect and lower rates of hypoglycaemia than glargine (IGlar). Data on children and adolescents are scarce.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
